Back to search

Article

PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis

2022-05-31

Abstract excerpt

<h4>Background: </h4> Heart failure (HF) is a global pandemic which affects about 26 million people. PFKM (Phosphofructokinase, Muscle), catalyzing the phosphorylation of fructose-6-phosphate, plays a very important role in cardiovascular diseases. However, the effect of PFKM in glycolysis and HF remains to be elucidated. <h4>Materials: </h4> and methods: H9c2 rat cardiomyocyte cells were used in this study. Cells...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5fd7dda8-b65e-5b71-9175-e3ac190d7f32
DOI
10.21203/rs.3.rs-1664969/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysisDOI 10.21203/rs.3.rs-1664969/v1
Select a neighboring publication to make it the new centre.